Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis

Objective To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to physical function and joint damage progression. Methods Five-year data from the BeSt...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2011-10, Vol.70 (10), p.1815-1821
Hauptverfasser: Klarenbeek, N B, Koevoets, R, van der Heijde, D M F M, Gerards, A H, ten Wolde, S, Kerstens, P J S M, Huizinga, T W J, Dijkmans, B A C, Allaart, C F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1821
container_issue 10
container_start_page 1815
container_title Annals of the rheumatic diseases
container_volume 70
creator Klarenbeek, N B
Koevoets, R
van der Heijde, D M F M
Gerards, A H
ten Wolde, S
Kerstens, P J S M
Huizinga, T W J
Dijkmans, B A C
Allaart, C F
description Objective To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to physical function and joint damage progression. Methods Five-year data from the BeSt study were used, a randomised clinical trial comparing four treatment strategies in 508 patients with recent-onset RA. Every three months disease activity was assessed with nine indices (Disease Activity Score (DAS), DAS-C reactive proteine (DAS-CRP), Disease Activity Score in 28 joints (DAS-28), DAS28-CRP, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and three DAS versions with adjusted tender joint scores) and categorized into remission, low, moderate and high disease activity (LDA, MDA, HDA). In addition, the recent ACR/EULAR clinical trial and practice remission was assessed 3-monthly with 28 and 68/66 joint counts. For each index, Generalized Estimating Equations analyses were performed to relate disease activity levels and the absence/presence of remission to 3-monthly assessments of physical functioning and annual radiological progression. Results From the composite indices, CDAI and SDAI were the most stringent definitions of remission and classified more patients as LDA. DAS28 and DAS28-CRP had the highest proportions of remission and MDA and a smaller proportion of LDA. ACR/EULAR remission percentages were comparable to CDAI/SDAI: remission percentages. The variant including CRP and 68/66 joint counts was the most stringent. For all indices, higher levels of disease activity were associated with decreased physical functioning and more radiological damage progression. Despite differences in classification between the indices, no major differences in relation to the two outcomes were observed. Conclusion The associations of nine composite indices and ACR/EULAR remission criteria with functional status and joint damage progression showed high accordance, whereas the proportions of patients classified in the disease activity levels differed.
doi_str_mv 10.1136/ard.2010.149260
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_887939112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>887939112</sourcerecordid><originalsourceid>FETCH-LOGICAL-b427t-ede0e3f884fcbf279c1cf294bf691185e0154d6c6bb5a22521da8a25718172213</originalsourceid><addsrcrecordid>eNqFkVFrFDEUhYModq0--yYBkYIw3SSTTDKPy9CqsFSstq8hk0k6WXcma5JB-zf8xWactYIvPl0u9zsnJxwAXmJ0jnFZrVXozgmaN1qTCj0CK0wrURBUocdghRAqC1pX_AQ8i3GXVySweApOCBa4ZFSswM9NjF47lZwf4XeXerjzbkywU4O6M1CNHTz099FptYd2GvXMufEOegvzNFD74eCjSwa6sXPaxN-S1BuYY2G4aa7XFzfbzTUMZnAxzq_okPHgVFbA0JtpUMm7DqqQ-nxx8Tl4YtU-mhfHeQpuLi--NO-L7cd3H5rNtmgp4akwnUGmtEJQq1tLeK2xtqSmra1qjAUzCDPaVbpqW6YIYQR3SijCeP47JwSXp-Bs8T0E_20yMcmcUJv9Xo3GT1EKwesyW5FMvv6H3PkpjDmcxJxzwTGiZabWC6WDjzEYKw_BDSrcS4zk3JbMbcm5Lbm0lRWvjr5TO5jugf9TTwbeHAEVcwM2qFG7-JejDBOGWeaKhXMxmR8PdxW-yoqXnMmr20Z-Es0V-3zLJc3824Vvh91_U_4CIu-5Qg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777871043</pqid></control><display><type>article</type><title>Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><creator>Klarenbeek, N B ; Koevoets, R ; van der Heijde, D M F M ; Gerards, A H ; ten Wolde, S ; Kerstens, P J S M ; Huizinga, T W J ; Dijkmans, B A C ; Allaart, C F</creator><creatorcontrib>Klarenbeek, N B ; Koevoets, R ; van der Heijde, D M F M ; Gerards, A H ; ten Wolde, S ; Kerstens, P J S M ; Huizinga, T W J ; Dijkmans, B A C ; Allaart, C F</creatorcontrib><description>Objective To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to physical function and joint damage progression. Methods Five-year data from the BeSt study were used, a randomised clinical trial comparing four treatment strategies in 508 patients with recent-onset RA. Every three months disease activity was assessed with nine indices (Disease Activity Score (DAS), DAS-C reactive proteine (DAS-CRP), Disease Activity Score in 28 joints (DAS-28), DAS28-CRP, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and three DAS versions with adjusted tender joint scores) and categorized into remission, low, moderate and high disease activity (LDA, MDA, HDA). In addition, the recent ACR/EULAR clinical trial and practice remission was assessed 3-monthly with 28 and 68/66 joint counts. For each index, Generalized Estimating Equations analyses were performed to relate disease activity levels and the absence/presence of remission to 3-monthly assessments of physical functioning and annual radiological progression. Results From the composite indices, CDAI and SDAI were the most stringent definitions of remission and classified more patients as LDA. DAS28 and DAS28-CRP had the highest proportions of remission and MDA and a smaller proportion of LDA. ACR/EULAR remission percentages were comparable to CDAI/SDAI: remission percentages. The variant including CRP and 68/66 joint counts was the most stringent. For all indices, higher levels of disease activity were associated with decreased physical functioning and more radiological damage progression. Despite differences in classification between the indices, no major differences in relation to the two outcomes were observed. Conclusion The associations of nine composite indices and ACR/EULAR remission criteria with functional status and joint damage progression showed high accordance, whereas the proportions of patients classified in the disease activity levels differed.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.2010.149260</identifier><identifier>PMID: 21813548</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Adult ; Aged ; Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Arthritis, Rheumatoid - physiopathology ; Arthritis, Rheumatoid - rehabilitation ; Biological and medical sciences ; Biomarkers - blood ; C-Reactive Protein - metabolism ; Classification ; Clinical medicine ; Clinical trials ; Disease Progression ; Diseases of the osteoarticular system ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Health risk assessment ; Hospitals ; Humans ; Inflammatory joint diseases ; Male ; Medical sciences ; Middle Aged ; Miscellaneous. Osteoarticular involvement in other diseases ; Remission Induction ; Rheumatoid arthritis ; Rheumatology ; Severity of Illness Index ; Studies ; Treatment Outcome</subject><ispartof>Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1815-1821</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>2015 INIST-CNRS</rights><rights>Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b427t-ede0e3f884fcbf279c1cf294bf691185e0154d6c6bb5a22521da8a25718172213</citedby><cites>FETCH-LOGICAL-b427t-ede0e3f884fcbf279c1cf294bf691185e0154d6c6bb5a22521da8a25718172213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/70/10/1815.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/70/10/1815.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77343,77374</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24512515$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21813548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klarenbeek, N B</creatorcontrib><creatorcontrib>Koevoets, R</creatorcontrib><creatorcontrib>van der Heijde, D M F M</creatorcontrib><creatorcontrib>Gerards, A H</creatorcontrib><creatorcontrib>ten Wolde, S</creatorcontrib><creatorcontrib>Kerstens, P J S M</creatorcontrib><creatorcontrib>Huizinga, T W J</creatorcontrib><creatorcontrib>Dijkmans, B A C</creatorcontrib><creatorcontrib>Allaart, C F</creatorcontrib><title>Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Objective To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to physical function and joint damage progression. Methods Five-year data from the BeSt study were used, a randomised clinical trial comparing four treatment strategies in 508 patients with recent-onset RA. Every three months disease activity was assessed with nine indices (Disease Activity Score (DAS), DAS-C reactive proteine (DAS-CRP), Disease Activity Score in 28 joints (DAS-28), DAS28-CRP, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and three DAS versions with adjusted tender joint scores) and categorized into remission, low, moderate and high disease activity (LDA, MDA, HDA). In addition, the recent ACR/EULAR clinical trial and practice remission was assessed 3-monthly with 28 and 68/66 joint counts. For each index, Generalized Estimating Equations analyses were performed to relate disease activity levels and the absence/presence of remission to 3-monthly assessments of physical functioning and annual radiological progression. Results From the composite indices, CDAI and SDAI were the most stringent definitions of remission and classified more patients as LDA. DAS28 and DAS28-CRP had the highest proportions of remission and MDA and a smaller proportion of LDA. ACR/EULAR remission percentages were comparable to CDAI/SDAI: remission percentages. The variant including CRP and 68/66 joint counts was the most stringent. For all indices, higher levels of disease activity were associated with decreased physical functioning and more radiological damage progression. Despite differences in classification between the indices, no major differences in relation to the two outcomes were observed. Conclusion The associations of nine composite indices and ACR/EULAR remission criteria with functional status and joint damage progression showed high accordance, whereas the proportions of patients classified in the disease activity levels differed.</description><subject>Adult</subject><subject>Aged</subject><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Arthritis, Rheumatoid - physiopathology</subject><subject>Arthritis, Rheumatoid - rehabilitation</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>C-Reactive Protein - metabolism</subject><subject>Classification</subject><subject>Clinical medicine</subject><subject>Clinical trials</subject><subject>Disease Progression</subject><subject>Diseases of the osteoarticular system</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Health risk assessment</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous. Osteoarticular involvement in other diseases</subject><subject>Remission Induction</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Severity of Illness Index</subject><subject>Studies</subject><subject>Treatment Outcome</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkVFrFDEUhYModq0--yYBkYIw3SSTTDKPy9CqsFSstq8hk0k6WXcma5JB-zf8xWactYIvPl0u9zsnJxwAXmJ0jnFZrVXozgmaN1qTCj0CK0wrURBUocdghRAqC1pX_AQ8i3GXVySweApOCBa4ZFSswM9NjF47lZwf4XeXerjzbkywU4O6M1CNHTz099FptYd2GvXMufEOegvzNFD74eCjSwa6sXPaxN-S1BuYY2G4aa7XFzfbzTUMZnAxzq_okPHgVFbA0JtpUMm7DqqQ-nxx8Tl4YtU-mhfHeQpuLi--NO-L7cd3H5rNtmgp4akwnUGmtEJQq1tLeK2xtqSmra1qjAUzCDPaVbpqW6YIYQR3SijCeP47JwSXp-Bs8T0E_20yMcmcUJv9Xo3GT1EKwesyW5FMvv6H3PkpjDmcxJxzwTGiZabWC6WDjzEYKw_BDSrcS4zk3JbMbcm5Lbm0lRWvjr5TO5jugf9TTwbeHAEVcwM2qFG7-JejDBOGWeaKhXMxmR8PdxW-yoqXnMmr20Z-Es0V-3zLJc3824Vvh91_U_4CIu-5Qg</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Klarenbeek, N B</creator><creator>Koevoets, R</creator><creator>van der Heijde, D M F M</creator><creator>Gerards, A H</creator><creator>ten Wolde, S</creator><creator>Kerstens, P J S M</creator><creator>Huizinga, T W J</creator><creator>Dijkmans, B A C</creator><creator>Allaart, C F</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ Publishing Group</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20111001</creationdate><title>Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis</title><author>Klarenbeek, N B ; Koevoets, R ; van der Heijde, D M F M ; Gerards, A H ; ten Wolde, S ; Kerstens, P J S M ; Huizinga, T W J ; Dijkmans, B A C ; Allaart, C F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b427t-ede0e3f884fcbf279c1cf294bf691185e0154d6c6bb5a22521da8a25718172213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Arthritis, Rheumatoid - physiopathology</topic><topic>Arthritis, Rheumatoid - rehabilitation</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>C-Reactive Protein - metabolism</topic><topic>Classification</topic><topic>Clinical medicine</topic><topic>Clinical trials</topic><topic>Disease Progression</topic><topic>Diseases of the osteoarticular system</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Health risk assessment</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous. Osteoarticular involvement in other diseases</topic><topic>Remission Induction</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Severity of Illness Index</topic><topic>Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klarenbeek, N B</creatorcontrib><creatorcontrib>Koevoets, R</creatorcontrib><creatorcontrib>van der Heijde, D M F M</creatorcontrib><creatorcontrib>Gerards, A H</creatorcontrib><creatorcontrib>ten Wolde, S</creatorcontrib><creatorcontrib>Kerstens, P J S M</creatorcontrib><creatorcontrib>Huizinga, T W J</creatorcontrib><creatorcontrib>Dijkmans, B A C</creatorcontrib><creatorcontrib>Allaart, C F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klarenbeek, N B</au><au>Koevoets, R</au><au>van der Heijde, D M F M</au><au>Gerards, A H</au><au>ten Wolde, S</au><au>Kerstens, P J S M</au><au>Huizinga, T W J</au><au>Dijkmans, B A C</au><au>Allaart, C F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>70</volume><issue>10</issue><spage>1815</spage><epage>1821</epage><pages>1815-1821</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Objective To compare nine disease activity indices and the new American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in rheumatoid arthritis (RA) and to relate these to physical function and joint damage progression. Methods Five-year data from the BeSt study were used, a randomised clinical trial comparing four treatment strategies in 508 patients with recent-onset RA. Every three months disease activity was assessed with nine indices (Disease Activity Score (DAS), DAS-C reactive proteine (DAS-CRP), Disease Activity Score in 28 joints (DAS-28), DAS28-CRP, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and three DAS versions with adjusted tender joint scores) and categorized into remission, low, moderate and high disease activity (LDA, MDA, HDA). In addition, the recent ACR/EULAR clinical trial and practice remission was assessed 3-monthly with 28 and 68/66 joint counts. For each index, Generalized Estimating Equations analyses were performed to relate disease activity levels and the absence/presence of remission to 3-monthly assessments of physical functioning and annual radiological progression. Results From the composite indices, CDAI and SDAI were the most stringent definitions of remission and classified more patients as LDA. DAS28 and DAS28-CRP had the highest proportions of remission and MDA and a smaller proportion of LDA. ACR/EULAR remission percentages were comparable to CDAI/SDAI: remission percentages. The variant including CRP and 68/66 joint counts was the most stringent. For all indices, higher levels of disease activity were associated with decreased physical functioning and more radiological damage progression. Despite differences in classification between the indices, no major differences in relation to the two outcomes were observed. Conclusion The associations of nine composite indices and ACR/EULAR remission criteria with functional status and joint damage progression showed high accordance, whereas the proportions of patients classified in the disease activity levels differed.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>21813548</pmid><doi>10.1136/ard.2010.149260</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1815-1821
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_miscellaneous_887939112
source MEDLINE; BMJ Journals - NESLi2
subjects Adult
Aged
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Arthritis, Rheumatoid - physiopathology
Arthritis, Rheumatoid - rehabilitation
Biological and medical sciences
Biomarkers - blood
C-Reactive Protein - metabolism
Classification
Clinical medicine
Clinical trials
Disease Progression
Diseases of the osteoarticular system
Drug Therapy, Combination
Female
Follow-Up Studies
Health risk assessment
Hospitals
Humans
Inflammatory joint diseases
Male
Medical sciences
Middle Aged
Miscellaneous. Osteoarticular involvement in other diseases
Remission Induction
Rheumatoid arthritis
Rheumatology
Severity of Illness Index
Studies
Treatment Outcome
title Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T14%3A52%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20with%20joint%20damage%20and%20physical%20functioning%20of%20nine%20composite%20indices%20and%20the%202011%20ACR/EULAR%20remission%20criteria%20in%20rheumatoid%20arthritis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Klarenbeek,%20N%20B&rft.date=2011-10-01&rft.volume=70&rft.issue=10&rft.spage=1815&rft.epage=1821&rft.pages=1815-1821&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.2010.149260&rft_dat=%3Cproquest_cross%3E887939112%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777871043&rft_id=info:pmid/21813548&rfr_iscdi=true